Alnylam Pharmaceuticals Inc at Chardan Genetic Medicines Conference (Virtual) Transcript
It's my pleasure to introduce our next guest from Alnylam Pharmaceuticals, Chief Executive Officer, John Maraganore. The format of this session is a roughly 25-minute fireside chat. (Operator Instructions)
With that, John, welcome. Thank you so much for joining us. And to start, could you just provide a couple of minutes of introductory comments about the state of business for Alnylam, summarizing your differentiated approach? And what's been achieved in 2021 year-to-date?
Yes. Thanks, Keay, and thanks for having us here. It's great to have this conversation with you.
Well, as you know, Alnylam really has led the discovery of RNAi therapeutics as a whole new class of medicines. We pioneered this approach. We brought 4 products to the market now that are being sold in over 30 countries around the world. That includes ONPATTRO for
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
